Abstract
Background: Neonatal infection is an important cause of neonatal mortality and morbidity. Group B Streptococcus agalactiae (GBS) during pregnancy and/or labor is one of the main risk factor for neonatal infection, which can be an early or a late, severe one.
Aim: To reduce neonatal morbidity and mortality.
Objectives: To study maternal and neonatal GBS incidence, to establish the need for perinatal treatment, to reduce the newborn care costs.
Material and Method: A retrospective study in Polizu Maternity between 2006-2009, in collaboration with “I. Cantacuzino” Institute for bacteriological serotyping. 14 538 newborns were included in this study.
Results: GBS morbidity is raising from 2006 to 2009. One third of newborns from GBS mothers were also infected. About 1% of them were treated for a severe infection - sepsis.
Conclusions: The incidence of GBS infection in pregnant women and newborns is raising. Early diagnosis and treatment in perinatal period can explain the reduction of neonatal mortality.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stoicescu, S., Broscauncianu, D. & Voicila, C. 877 Group B Streptococcus - Frequently Risk Factor for Early Neonatal Infection. Pediatr Res 68 (Suppl 1), 440 (2010). https://doi.org/10.1203/00006450-201011001-00877
Issue date:
DOI: https://doi.org/10.1203/00006450-201011001-00877
